Skip to main content

Advertisement

SpringerLink
Log in

Effects of in vivo and in vitro administration of neuro-Behcet’s disease IgG

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Antibodies directed against membrane antigens of neuronal axonal processes (neuropil) have been recently identified in neuro-Behcet’s disease (NBD) patients. To delineate the potential pathogenic action of these antibodies, pooled sera from seven NBD patients with neuropil antibodies and seven healthy controls were divided into purified IgG and IgG-depleted serum (IgG-DS) fractions and each fraction was administered into lateral ventricles of rats. NBD IgG-injected rats showed reduced locomotor activity in the open field test as compared to NBD IgG-DS, healthy control IgG, healthy control IgG-DS and PBS injected rats (n = 10 for each group). There were no significant differences among treatment groups by means of anxiety-like behaviors (assessed by elevated plus maze test) and learning/memory functions (assessed by passive avoidance test). Administration of NBD IgG on cultured SH-SY5Y neuroblastoma cells induced significantly increased cell death and apoptosis (as measured by nucleosome levels in the supernatants) as compared to other treatment groups. Our results suggest that IgGs isolated from sera of neuropil antibody-positive NBD patients have a neurotoxic action, which is presumably mediated by apoptotic mechanisms. Motor deficits frequently observed in NBD patients might at least partially be caused by the pathogenic action of anti-neuronal IgG.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Gül A (2015) Pathogenesis of Behçet’s disease: autoinflammatory features and beyond. Semin Immunopathol 37:413–418

    Article  PubMed  Google Scholar 

  2. Saip S, Akman-Demir G, Siva A (2014) Neuro-Behçet syndrome. Handb Clin Neurol 121:1703–1723

    Article  PubMed  Google Scholar 

  3. Akman-Demir G, Serdaroglu P, Tasçi B (1999) Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients. The Neuro-Behçet Study Group. Brain 122:2171–2182

    Article  PubMed  Google Scholar 

  4. Yesilot N, Shehu M, Oktem-Tanor O, Serdaroglu P, Akman-Demir G (2006) Silent neurological involvement in Behçet’s disease. Clin Exp Rheumatol 24:S65–S70

    CAS  PubMed  Google Scholar 

  5. Akman-Demir G, Mutlu M, Kiyat-Atamer A et al (2015) Behçet’s disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria. Clin Exp Rheumatol 33:S80–S84

    PubMed  Google Scholar 

  6. Vural B, Uğurel E, Tüzün E et al (2011) Anti-neuronal and stress-induced-phosphoprotein 1 antibodies in neuro-Behçet’s disease. J Neuroimmunol 239:91–97

    Article  CAS  PubMed  Google Scholar 

  7. Vural B, Sehitoğlu E, Cavuş F et al (2013) Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behçet’s disease. J Neuroimmunol 263:139–144

    Article  CAS  PubMed  Google Scholar 

  8. Taşçi B, Direskeneli H, Serdaroglu P, Akman-Demir G, Eraksoy M, Saruhan-Direskeneli G (1998) Humoral immune response to mycobacterial heat shock protein (hsp)65 in the cerebrospinal fluid of neuro-Behçet patients. Clin Exp Immunol 113:100–104

    Article  PubMed  PubMed Central  Google Scholar 

  9. Gheita TA, Samir H, Hussein H (2012) Anti-annexin V antibodies in neuro-Behçet patients: clinical significance and relation to disease activity. Int J Rheum Dis 15:e124–e126

    Article  PubMed  Google Scholar 

  10. Planagumà J, Leypoldt F, Mannara F et al (2015) Human N-methyl d-aspartate receptor antibodies alter memory and behaviour in mice. Brain 138:94–109

    Article  PubMed  Google Scholar 

  11. Ohkawa T, Fukata Y, Yamasaki M et al (2013) Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci 33:18161–18174

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080

    Google Scholar 

  13. Irani SR, Alexander S, Waters P et al (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain 133:2734–2748

    Article  PubMed  PubMed Central  Google Scholar 

  14. Furneaux HM, Rosenblum MK, Dalmau J, Wong E, Woodruff P, Graus F, Posner JB (1990) Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med 322:1844–1851

    Article  CAS  PubMed  Google Scholar 

  15. Cattoretti G, Pileri S, Parravicini C et al (1993) Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 171:83–98

    Article  CAS  PubMed  Google Scholar 

  16. Tüzün E, Zhou L, Baehring JM, Bannykh S, Rosenfeld MR, Dalmau J (2009) Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol 118:737–743

    Article  PubMed  PubMed Central  Google Scholar 

  17. Dalmau J, Gultekin SH, Voltz R et al (1999) Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain 122:27–39

    Article  PubMed  Google Scholar 

  18. Verschuuren JJ, Dalmau J, Hoard R, Posner JB (1997) Paraneoplastic anti-Hu serum: studies on human tumor cell lines. J Neuroimmunol 79:202–210

    Article  CAS  PubMed  Google Scholar 

  19. Colpak AI, Gursoy-Ozdemir Y, Kalyoncu U (2014) Sera from patients with neuro-Behcet’s disease contain autoantibodies against vascular and nervous tissue. Arch Neuropsychiatr 51:141–147

    Article  Google Scholar 

  20. Gasperi C, Stüve O, Hemmer B (2016) B cell-directed therapies in multiple sclerosis. Neurodegener Dis Manag 6:37–47

    Article  PubMed  Google Scholar 

  21. Hohlfeld R, Dornmair K, Meinl E, Wekerle H (2016) The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research. Lancet Neurol 15:317–331

    Article  CAS  PubMed  Google Scholar 

  22. Krumbholz M, Derfuss T, Hohlfeld R, Meinl E (2012) B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nat Rev Neurol 8:613–623

    Article  CAS  PubMed  Google Scholar 

  23. Meinl E, Derfuss T, Krumbholz M, Pröbstel AK, Hohlfeld R (2011) Humoral autoimmunity in multiple sclerosis. J Neurol Sci 306:180–182

    Article  CAS  PubMed  Google Scholar 

  24. Seider N, Beiran I, Scharf J, Miller B (2001) Intravenous immunoglobulin therapy for resistant ocular Behçet’s disease. Br J Ophthalmol 85:1287–1288

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Erdoğan S, Sorgun MH, Yalçındağ N, Atilla H, Yücesan C (2015) Bilateral optic neuritis in a patient with Behçet’s disease who respond to therapeutic plasma exchange. Saudi J Ophthalmol 29:298–300

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kidd DP (2015) Rituximab is effective in severe treatment-resistant neurological Behçet’s syndrome. J Neurol 262:2676–2677

    Article  CAS  PubMed  Google Scholar 

  27. Kowal C, Degiorgio LA, Lee JY, Edgar MA, Huerta PT, Volpe BT, Diamond B (2006) Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci USA 103:19854–19859

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This study was supported by The Istanbul University Department of Scientific Research Projects (Project Nos: 31478 and 46421) and The Scientific and Technological Research Council of Turkey (TÜBİTAK) (Project No: 113S570).

Author information

Authors and Affiliations

  1. Department of Neuroscience, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey

    Ece Erdağ, Cem İsmail Küçükali, Melike Küçükerden & Erdem Tüzün

  2. Department of Pharmacology and Psychopharmacology Research Unit, Marmara University, Istanbul, Turkey

    Ceren Şahin & Feyza Arıcıoğlu

  3. Department of Molecular Medicine, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey

    Sinem Bireller & Bedia Cakmakoglu

  4. Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

    Murat Kürtüncü

  5. Department of Neurology, Haydarpasa Numune Education and Research Hospital, Istanbul University, Istanbul, Turkey

    Recai Türkoğlu

Authors
  1. Ece Erdağ
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ceren Şahin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cem İsmail Küçükali
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sinem Bireller
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Melike Küçükerden
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Murat Kürtüncü
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Recai Türkoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bedia Cakmakoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Erdem Tüzün
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Feyza Arıcıoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erdem Tüzün.

Ethics declarations

Conflict of interest

Authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Erdağ, E., Şahin, C., Küçükali, C.İ. et al. Effects of in vivo and in vitro administration of neuro-Behcet’s disease IgG. Neurol Sci 38, 833–843 (2017). https://doi.org/10.1007/s10072-017-2856-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-017-2856-2

Keywords

Search

Navigation